Hypersensitivity, Immediate  >>  GSK870086 inhalation  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK870086 inhalation / GSK
NCT00857857: A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics

Completed
2
24
Europe
GW870086X, FP, Placebo
GlaxoSmithKline
Asthma
11/09
11/09
NCT01299610: A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo

Completed
2
25
Europe
GW870086 2.0%, GW870086 0.2%, FP 0.05%, Placebo
GlaxoSmithKline
Dermatitis, Atopic
03/11
04/11
NCT01245426: A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)

Completed
2
136
Europe, RoW
GW870086 2mg, GW870086 4mg, GW870086 Placebo, GW870086 1mg, GW870086 3mg
GlaxoSmithKline
Asthma
07/11
08/11

Download Options